These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Immunomodulatory drugs for the treatment of periorbital necrobiotic xanthogranuloma. Abdul-Hay M Clin Adv Hematol Oncol; 2013 Oct; 11(10):680-1. PubMed ID: 24518383 [No Abstract] [Full Text] [Related]
8. Necrobiotic xanthogranuloma of the extremities. Wolz M; Peters MS J Drugs Dermatol; 2012 Jan; 11(1):122-3. PubMed ID: 22206088 [No Abstract] [Full Text] [Related]
9. An unusual histologic variant of necrobiotic xanthogranuloma. Ziemer M; Norgauer J; Simon JC; Koehler MJ Am J Dermatopathol; 2012 Apr; 34(2):e22-6. PubMed ID: 22441374 [TBL] [Abstract][Full Text] [Related]
10. Necrobiotic xanthogranuloma. Rose A; Robinson M; Kamino H; Latkowski JA Dermatol Online J; 2012 Dec; 18(12):30. PubMed ID: 23286820 [TBL] [Abstract][Full Text] [Related]
11. A patient with necrobiotic xanthogranuloma presenting with an anterior mediastinal mass, plasma cell dyscrasia, and a lymphoproliferative disorder. Chen KY; Leslie W; Mahon B; Venugopal P Clin Adv Hematol Oncol; 2011 Sep; 9(9):696-700. PubMed ID: 22402515 [No Abstract] [Full Text] [Related]
12. Necrobiotic xanthogranuloma of the extremities with paraproteinemia and without periorbital involvement at presentation. Hashemi P; Rashidi A; Chapas AM; Balfour EM Cutis; 2012 Jan; 89(1):41-4. PubMed ID: 22439311 [TBL] [Abstract][Full Text] [Related]